Live Therapeutic Goods Administration News with Latest Updates

Live Therapeutic Goods Administration news and developments with the latest updates. Check out current Therapeutic Goods Administration news stories and find out what happened, what is going on with Therapeutic Goods Administration. Recent news updates about Therapeutic Goods Administration
Top 3 Covid vaccine questions – Children and delta variant, Covid risk after vaccine, and opening borders
Vitamins and minerals aren’t risk-free
Should we vaccinate children against COVID-19?
RACGP backs vaccine rollout changes for younger people
ATAGI statement regarding vaccination of adolescents aged 12
Black Ant King tablets
Neutrogena Ultra Sheer Body Mist Sunscreen Spray SPF 50+
National Cabinet’s plan out of COVID aims too low on vaccinations and leaves crucial questions unanswered
Canberra dental practice fined $266,400 for alleged unlawful supply of dental implants and bone grafts
One Night Love tablets
ATAGI update following weekly Covid meeting
Gold Ant tablets
Seeking members for Statutory Advisory Committees and Australian Influenza Vaccine Committee
Evolution Supplements Australia and its Director penalised total of $12 million for advertising illegal sports supplements
Sydney-based individual fined $10,656 for alleged unlawful advertising of medicinal cannabis
Vaccine Operations Centre – Weekly Operational Update 28 July
Compass Cannabis moves into Australia with first internationally operated clinics
Vaccine Operations Centre – Weekly Operational Update 27 July
Whipping cream canisters have many uses beyond ‘nangs’
To ensure supply of top 3 drugs used to treat COVID-19, it’s time to boost domestic medicine manufacturing
Updated ATAGI advice on Covid Vaccine AstraZeneca in response to Delta outbreaks
Canberra individual fined $2,664 for alleged unlawful advertising of homoeopathic medicine in relation to COVID-19
National Cabinet Statement 23 July
AMA says AstraZeneca vaccine critical to combat growing Covid-19 Delta outbreak
Pfizer COVID-19 vaccine – Addition of safety information about myocarditis and pericarditis to Product Information
ATAGI update following weekly COVID-19 meeting 23 July
TGA approves Pfizer COVID-19 vaccine for 12 to 15-year-olds
Death of Tasmanian man following AstraZeneca vaccination
Shortages of tocilizumab medicines
Benefits of a COVID vaccine far outweigh small risk of treatable heart inflammation
Teens should have a say in whether they get a COVID vaccine
ATAGI update following weekly COVID-19 meeting 15 July
Vaccine Operations Centre – Weekly Operational Update 15 July
Psychedelic microdosing study to reveal what really happens in brains
ATAGI statement on use of COVID-19 vaccines in an outbreak setting
World’s first regulated disinfectant that protects against COVID-19 and Influenza A & B for up
Do public need clearer guidance when it comes to vaccine messaging?
ATAGI update following weekly COVID-19 meeting 8 July
Top 3 COVID-19 vaccine questions – Pandemic fatigue, what to ask your GP and changing advice
Low-cost, natural quit smoking aid is effective, needs wider global access
Chief Nursing and Midwifery Officer opinion piece on improved COVID safety levels
Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness
Starpharma Holdings Limited fined $93,240 for alleged unlawful advertising of ‘Viraleze’ in relation to COVID-19
COVID-19 indemnity scheme to protect health professionals and patients
ATAGI update following weekly COVID-19 meeting 1 July
BiomeBank submits for market authorisation of world-first microbial therapy
Top 3 COVID-19 vaccine questions – COVID-19 vaccines and aged care, symptoms after vaccine, and mixing vaccines
Australian biotech submits for approval of world first microbial therapy